Reliable Characterization of Organic & Pharmaceutical Compounds with High Resolution Monochromated EEL Spectroscopy

dc.contributor.authorDas, Partha Pratim
dc.contributor.authorGuzzinati, Giulio
dc.contributor.authorColl, Cristina
dc.contributor.authorGómez Pérez, Alejandro
dc.contributor.authorNicolopoulos, Stavros
dc.contributor.authorEstradé Albiol, Sònia
dc.contributor.authorPeiró Martínez, Francisca
dc.contributor.authorVerbeeck, Johan
dc.contributor.authorZompra, Aikaterini A.
dc.contributor.authorGalanis, Athanassios S.
dc.date.accessioned2021-04-15T09:10:18Z
dc.date.available2021-04-15T09:10:18Z
dc.date.issued2020-06-27
dc.date.updated2021-04-15T09:10:18Z
dc.description.abstractOrganic and biological compounds (especially those related to the pharmaceutical industry) have always been of great interest for researchers due to their importance for the development of new drugs to diagnose, cure, treat or prevent disease. As many new API (active pharmaceutical ingredients) and their polymorphs are in nanocrystalline or in amorphous form blended with amorphous polymeric matrix (known as amorphous solid dispersion-ASD), their structural identification and characterization at nm scale with conventional X-Ray/Raman/IR techniques becomes difficult. During any API synthesis/production or in the formulated drug product, impurities must be identified and characterized. Electron energy loss spectroscopy (EELS) at high energy resolution by transmission electron microscope (TEM) is expected to be a promising technique to screen and identify the different (organic) compounds used in a typical pharmaceutical or biological system and to detect any impurities present, if any, during the synthesis or formulation process. In this work, we propose the use of monochromated TEM-EELS, to analyze selected peptides and organic compounds and their polymorphs. In order to validate EELS for fingerprinting (in low loss/optical region) and by further correlation with advanced DFT, simulations were utilized.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec708791
dc.identifier.issn2073-4360
dc.identifier.pmid32605004
dc.identifier.urihttps://hdl.handle.net/2445/176302
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/polym12071434
dc.relation.ispartofPolymers, 2020, vol. 12, num. 7, p. 1434
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/731019/EU//EUSMI
dc.relation.urihttps://doi.org/10.3390/polym12071434
dc.rightscc-by (c) Das, Partha Pratim et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Enginyeria Electrònica i Biomèdica)
dc.subject.classificationIndústria farmacèutica
dc.subject.classificationDaltonisme
dc.subject.otherPharmaceutical industry
dc.subject.otherColor blindness
dc.titleReliable Characterization of Organic & Pharmaceutical Compounds with High Resolution Monochromated EEL Spectroscopy
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
708791.pdf
Mida:
2.6 MB
Format:
Adobe Portable Document Format